InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (122 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
122
T+90 hit rate
0%
T+90 mean return
-9.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Susi Roger E., Founder, Chairman, Chief Executive Officer and President. Insider active across 1 company, notably Iradimed CORP. Cumulatively, 124 disclosures have been recorded. Split: 0 buy · 122 sells. Total volume traded: €30m. Activity tracked since 21 June 2021. The latest transaction was filed on 28 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations124 total
2,819 shares@ US$88.980.019% mcap0.7% of flowCommon StockSEC:0001613801-26-000028:0
931 shares@ US$89.700.0063% mcap0.2% of flowCommon StockSEC:0001613801-26-000028:1
998 shares@ US$84.130.0063% mcap0.2% of flowCommon StockSEC:0001613801-26-000028:2
847 shares@ US$85.770.0055% mcap0.2% of flowCommon StockSEC:0001613801-26-000028:3
742 shares@ US$86.520.0048% mcap0.2% of flowCommon StockSEC:0001613801-26-000028:4
900 shares@ US$88.000.0060% mcap0.2% of flowCommon StockSEC:0001613801-26-000028:5
263 shares@ US$88.810.0018% mcap0.1% of flowCommon StockSEC:0001613801-26-000028:6
3,580 shares@ US$93.140.025% mcap0.9% of flowCommon StockSEC:0001613801-26-000026:0
1,420 shares@ US$93.900.0100% mcap0.3% of flowCommon StockSEC:0001613801-26-000026:1
1,162 shares@ US$89.730.0078% mcap0.3% of flowCommon StockSEC:0001613801-26-000026:2
140 shares@ US$90.600.0010% mcap0.0% of flowCommon StockSEC:0001613801-26-000026:3
606 shares@ US$91.650.0042% mcap0.1% of flowCommon StockSEC:0001613801-26-000026:4
592 shares@ US$92.660.0041% mcap0.1% of flowCommon StockSEC:0001613801-26-000026:5
1,847 shares@ US$91.840.013% mcap0.4% of flowCommon StockSEC:0001613801-26-000024:0
2,564 shares@ US$92.790.018% mcap0.6% of flowCommon StockSEC:0001613801-26-000024:1
589 shares@ US$93.450.0041% mcap0.1% of flowCommon StockSEC:0001613801-26-000024:2
2,107 shares@ US$93.710.015% mcap0.5% of flowCommon StockSEC:0001613801-26-000024:3
393 shares@ US$94.550.0028% mcap0.1% of flowCommon StockSEC:0001613801-26-000024:4
982 shares@ US$95.580.2% of flowCommon StockSEC:0001613801-26-000022:4
1,357 shares@ US$95.210.3% of flowCommon StockSEC:0001613801-26-000022:0
3,074 shares@ US$96.240.8% of flowCommon StockSEC:0001613801-26-000022:1
569 shares@ US$96.780.1% of flowCommon StockSEC:0001613801-26-000022:2
1,518 shares@ US$94.360.4% of flowCommon StockSEC:0001613801-26-000022:3
5,848 shares@ US$94.811.8% of flowCommon StockSEC:0001613801-26-000020:0
1,497 shares@ US$95.660.5% of flowCommon StockSEC:0001613801-26-000020:1
25 of 124 declarations
About Susi Roger E.
Public sources indicate that Roger Susi is the founder, chairman, chief executive officer, and president of IRadimed Corporation. IRadimed’s 2025 annual report says he also founded Invivo Research, now owned by Koninklijke Philips NV, and that he and his affiliates beneficially owned about 36% of the outstanding common stock as of December 31, 2024. IRadimed’s investor relations page confirms that the latest annual filing was dated March 6, 2026, and the latest proxy statement was dated April 30, 2026. Sources: https://www.sec.gov/Archives/edgar/data/1325618/000162828026028920/ars_proxyxirmdxcurrentxfol.pdf
